Gilead Sciences
GILD
2,013 hedge funds and large institutions have $119B invested in Gilead Sciences in 2025 Q1 according to their latest regulatory filings, with 275 funds opening new positions, 692 increasing their positions, 828 reducing their positions, and 112 closing their positions.
146% more first-time investments, than exits
New positions opened: 275 | Existing positions closed: 112
86% more funds holding in top 10
Funds holding in top 10: 28 → 52 (+24)
21% more capital invested
Capital invested by funds: $98.5B → $119B (+$20.8B)
7% more funds holding
Funds holding: 1,887 → 2,013 (+126)
0% more call options, than puts
Call options by funds: $1.2B | Put options by funds: $1.19B
0.12% more ownership
Funds ownership: 85.38% → 85.5% (+0.12%)
16% less repeat investments, than reductions
Existing positions increased: 692 | Existing positions reduced: 828
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.88B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.15B |
| 3 |
JP Morgan Chase
New York
|
+$564M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$243M |
| 5 |
Holocene Advisors
New York
|
+$238M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$1.87B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$856M |
| 3 |
BlackRock
New York
|
-$439M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$370M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$344M |
GILD Hedge Fund Activity: Q1 2025 in Review
2,013 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q1 2025, worth a combined $119B — up 21% from $98.5B a quarter earlier.
Buyers outnumbered sellers: 275 funds opened new GILD positions and 112 closed out — a net gain of 163 holders — while 692 added to existing stakes and 828 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $1.88B. The largest seller was Capital World Investors, cutting an estimated $1.87B.
- 2,013 institutional investors held Gilead Sciences (GILD) as of Q1 2025, up from 1,887 in Q4 2024.
- Funds reported $119B of Gilead Sciences stock for Q1 2025, up 21% quarter-over-quarter.
- 275 funds opened new Gilead Sciences positions in Q1 2025 and 112 closed out, a net change of +163 holders.
- The largest Gilead Sciences buyer in Q1 2025 was Fidelity Investments, an estimated $1.88B added.
- The largest Gilead Sciences seller in Q1 2025 was Capital World Investors, an estimated $1.87B sold.
Based on aggregated 13F filings for Q1 2025.